Foley & Lardner LLP represented TCG Crossover on the deal.TCG Crossover acted as the lead investor in KalVista Pharmaceuticals’ $58 million registered direct offering. KalVista Pharmaceuticals,…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Martina Bellini
…
This content is for Standard 1 Year members only. LoginJoin Now